|We are pleased to announce the recruitment of Ronald Buckanovich, MD, PhD and Lan Coffman, MD, PhD to the Division of Hematology-Oncology in the Department of Medicine, to the Division of Gynecology-Oncology in the Department of Obstetrics, Gynecology and Reproductive Science and Magee Womens Research Institute, and to the UPMC Hillman Cancer Center.|
|Ronald Buckanovich, MD, PhD|
|We are delighted to announce the appointment of Ronald Buckanovich, MD, PhD as Professor of Medicine in the Division of Hematology-Oncology, Professor of Obstetrics, Gynecology and Reproductive Science in the Division of Gynecology-Oncology, Co-Leader of the Breast and Ovarian Cancer Program at the UPMC Hillman Cancer Center, and Co-Director of the UPMC Ovarian Cancer Center of Excellence. Dr. Buckanovich joined the faculty on September 1, 2017.
Dr. Buchanovich will play an integral role in the establishment of a Comprehensive Ovarian Biology Research Center at Magee Womens Research Institute and the University of Pittsburgh School of Medicine, which will bring together biology and oncology researchers to study the molecular and physiological factors that mediate the development of ovarian cancer.
Dr. Buckanovich received his BS in Human Genetics and Biochemistry from Cornell University in 1990. In 1998, he graduated with his MD and PhD degrees from the Cornell, Memorial Sloan Kettering, Rockefeller University Tri-Institutional Medical Scientist training program. During his graduate training, he worked in the laboratory of Dr. Robert Darnell studying the molecular mechanisms of an ovarian cancer associated autoimmune neurologic disease known as POMA. He then went on to do his training in internal medicine and fellowship training in hematology-medical oncology at the University of Pennsylvania. Following the completion of his fellowship training, he stayed on at the University of Pennsylvania as an Instructor in the Division of Hematology-Oncology for two years, and in 2006, he was recruited to the University of Michigan as Assistant Professor of Obstetrics and Gynecology. Over the next 11 years, he stayed at Michigan and was promoted to Associate Professor with tenure of Internal Medicine and Obstetrics and Gynecology and the Thomas H. Simpson Collegiate Professor.
He is a highly accomplished investigator and is a leading expert in ovarian cancer biology with a specific focus on investigating the role of ovarian cancer stem-like cells and the ovarian cancer niche. At the University of Michigan, he initiated several clinical trials based upon his laboratory studies. His research group has developed two new classes of drugs to be translated for first-in-man clinical trials. Ron’s work has been supported by a variety of peer-reviewed funding mechanisms including multiple grants from the NCI/NIH, a Department of Defense grant, all in the general area of ovarian cancer. He has served as a member of the editorial board for a number of journals including Cancer Research and Journal of Translational Research.
Given his significant accomplishments in the field of ovarian cancer, in the spring of 2017, he was recruited here to Pittsburgh to the Division of Hematology-Oncology of the University of Pittsburgh School of Medicine as Professor of Medicine with a secondary appointment in the Division of Gynecology-Oncology of the Department of Obstetrics, Gynecology and Reproductive Science.
|Lan Coffman, MD|
|We are delighted to announce the appointment of Lan Coffman, MD, PhD as Assistant Professor of Medicine in the Division of Hematology-Oncology, Assistant Professor of Obstetrics, Gynecology and Reproductive Science in the Division of Gynecology-Oncology, and member of the Breast and Ovarian Cancer Program at the UPMC Hillman Cancer Center. Dr. Coffman joined the faculty on August 1, 2017.
Dr. Coffman was a member of the MD/PhD Joint Degree Program, and she received her PhD degree in Molecular Medicine in 2008 and her MD degree from the Wake Forest University School of Medicine in Winston-Salem, North Carolina. She was recruited to the Physician-Scientist Program of the internal medicine residency program at the University of Michigan in Ann Arbor, which she completed in 2012 and then stayed on at Michigan for fellowship training in hematology/oncology. At the completion of her fellowship in 2016, she was recruited to be clinical lecturer in the Division of Hematology-Oncology. Given her significant research focus in the area of ovarian cancer biology, she was recruited here to Pittsburgh in the winter of 2017 to the Division of Hematology-Oncology of the University of Pittsburgh School of Medicine as Assistant Professor of Medicine with a secondary appointment in the Division of Gynecology-Oncology of the Department of Obstetrics, Gynecology, & Reproductive Medicine.
Dr. Coffman’s research interests are focused on investigating ovarian cancer biology, the ovarian cancer tumor microenvironment, the role of mesenchymal stem cells, and mechanisms of metastasis and the formation of the metastatic microenvironment. In recognition of her research, she has received peer-reviewed funding from the American Cancer Society and the NCI/NIH. Her research laboratory is based in the Magee Womens Research Institute (MWRI) in the Comprehensive Ovarian Biology Research Center. With respect to her clinical interests, Dr. Coffman specializes in the treatment and development of novel agents and treatment regimens for gynecologic malignancies with a particular focus on ovarian cancer.
Please join us in welcoming Drs. Buckanovich and Coffman and their respective families to Pittsburgh.